Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
$2.66
+4.9%
$2.65
$2.15
$88.75
$18.87M-0.58784,718 shs285,886 shs
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$0.96
-2.1%
$0.96
$0.58
$1.39
$74.95M0.93128,551 shs30,010 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.56
+4.5%
$2.54
$2.07
$3.80
$78.43M0.6237,652 shs26,194 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.77
-1.4%
$4.62
$4.01
$9.33
$78.44M1.3204,775 shs41,868 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
+4.53%-10.61%+12.26%-15.85%-93.36%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-1.44%-1.18%-1.04%+1.61%+26.07%
InspireMD, Inc. stock logo
NSPR
InspireMD
+4.49%+12.28%+4.49%-20.50%+1.19%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-1.45%+1.92%+7.19%-0.21%-15.43%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
2.662 of 5 stars
3.52.00.00.02.33.30.6
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
1.6899 of 5 stars
3.50.00.00.00.02.50.6
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.9782 of 5 stars
3.61.00.00.02.60.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
3.00
Buy$22.83760.01% Upside
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3.00
Buy$1.2530.89% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5075.78% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67144.58% Upside

Current Analyst Ratings Breakdown

Latest ALUR, MLSS, NSPR, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/27/2025
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$2.50 ➝ $2.50
3/21/2025
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
3/21/2025
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$2.50
3/11/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $13.00
(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
$28.30M0.70N/AN/A($36.95) per share-0.07
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$8.61M8.70N/AN/A$0.11 per share8.68
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M11.16N/AN/A$1.83 per share1.40
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$39.49M1.99$0.05 per share96.29$2.98 per share1.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
-$80.61M-$12.50N/AN/AN/A-71.24%N/A-56.75%8/12/2025 (Estimated)
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-$6.93M-$0.07N/AN/A-52.01%-60.26%-40.23%N/A
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1011.9320.74N/A15.90%12.60%11.38%8/14/2025 (Estimated)

Latest ALUR, MLSS, NSPR, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/14/2025Q1 2025
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
-$1.53$0.43+$1.96$0.20$5.50 million$5.58 million
3/26/2025Q4 2024
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
-$5.00-$7.00-$2.00-$7.95$5.60 million$5.59 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
N/AN/AN/AN/AN/A
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
N/A
2.33
2.09
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/A
2.85
1.86
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
10.52
7.89

Institutional Ownership

CompanyInstitutional Ownership
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
21.39%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
5.79%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
22.40%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
24.75%
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allurion Technologies Inc. stock logo
ALUR
Allurion Technologies
5017.46 million2.01 millionOptionable
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3078.48 million58.61 millionOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.45 million14.85 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Allurion Technologies stock logo

Allurion Technologies NYSE:ALUR

$2.66 +0.13 (+4.94%)
Closing price 05/29/2025 03:59 PM Eastern
Extended Trading
$2.54 -0.11 (-4.14%)
As of 05/29/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Milestone Scientific stock logo

Milestone Scientific NYSE:MLSS

$0.96 -0.02 (-2.05%)
Closing price 05/29/2025 04:00 PM Eastern
Extended Trading
$0.96 0.00 (0.00%)
As of 05/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.56 +0.11 (+4.49%)
Closing price 05/29/2025 04:00 PM Eastern
Extended Trading
$2.52 -0.04 (-1.72%)
As of 05/29/2025 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.77 -0.07 (-1.45%)
Closing price 05/29/2025 04:00 PM Eastern
Extended Trading
$4.76 0.00 (-0.10%)
As of 05/29/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.